MetaCap

ClearPoint Neuro Inc. (CLPT)

NASDAQ: CLPTHealth CareMedical/Dental InstrumentsUSD

6.91-0.40 (-5.47%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CLPT stock chart

Technical analysis

Key statistics

All statistics
Market cap
$221.49M
EPS (TTM)
-$1.21
52-week range
6.85 – 19.63
Day range
6.85 – 7.45
Volume / Avg
1.11M / 701.64K
Beta
—

52-week range

$6.85$19.63

CLPT stock today

ClearPoint Neuro (CLPT) closed at $6.91 on Nov 20, down 5.47% (-$0.40), versus the S&P 500's 3.70% decline. Shares are 64.8% below their 52-week high of $19.63, set on Jun 29, 2026 and 0.9% above the 52-week low of $6.85, near the bottom of the past year's range. CLPT is down 49.5% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 50.0%.

ClearPoint Neuro has posted a net loss over the last twelve months (EPS of -$1.21), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About ClearPoint Neuro

Company profile

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform.

Industry
Medical/Dental Instruments
CEO
Mr. Joseph Michael Burnett
Headquarters
Solana Beach, CA
Employees
172

Financial highlights

Full financials

In fiscal 2025, ClearPoint Neuro generated $37.0 million in revenue, up 17.8% from fiscal 2024, its 7th consecutive year of revenue growth. ClearPoint Neuro reported a net loss of $25.5 million, compared with a loss of $18.9 million a year earlier. Gross margin was 61.4% (up from 60.9%) and operating margin -65.4%.

ClearPoint Neuro annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$36.97M$31.39M$23.95M$20.55M$16.30M
Growth+17.78%+31.04%+16.56%+26.09%+27.05%
Net income$-25.54M$-18.91M$-22.09M$-16.43M$-14.41M
EPS (diluted)$-0.90$-0.70$-0.90$-0.68$-0.69

Analyst forecast

Forecast

Consensus (2 analysts)

none

Avg. price target

$21.50+211.14%

  • Strong buy 0
  • Buy 2
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $18.00High $25.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 28, 2026
EPS actual vs est.
$-0.24 vs $-0.32
Surprise
+25.00%

CLPT news

All CLPT news

ClearPoint Neuro peers

Health Care sector
CLPT peer companies
CompanyPrice% ChgMarket capCompare
PROFProfound Medical Corp.6.38-3.19%$233.68Mvs CLPT
OSUROraSure Technologies Inc.3.46-4.16%$238.90Mvs CLPT
KTWOK2 Capital Acquisition Corporation Class A10.130.00%$203.02Mvs CLPT
PDEXPro-Dex Inc.63.00-0.77%$201.60Mvs CLPT
UTMDUtah Medical Products Inc.69.49-2.07%$198.01Mvs CLPT
OFIXOrthofix Medical Inc.6.07-4.26%$247.41Mvs CLPT
SSIISS Innovations International Inc.1.27-0.78%$254.86Mvs CLPT
ANIKAnika Therapeutics Inc.13.23-0.38%$177.22Mvs CLPT

Indexes, lists and sector

ClearPoint Neuro stock FAQ

What is ClearPoint Neuro's stock price today?

CLPT last traded at $6.91 as of Nov 20, 4:00 PM EST, down 5.47% on the day. Prices are delayed at least 15 minutes.

Does ClearPoint Neuro pay a dividend?

No. ClearPoint Neuro does not currently pay a regular cash dividend.

Who is ClearPoint Neuro's CEO?

Mr. Joseph Michael Burnett is the chief executive officer of ClearPoint Neuro Inc., which has about 172 employees.

Has CLPT ever split its stock?

Yes. The most recent CLPT stock split was a 1-for-40 split on Jul 27, 2016.

What is the CLPT 52-week high?

The 52-week high for CLPT is $19.63 and the 52-week low is $6.85. The stock is currently 64.8% below its high.

Compare CLPT